New Cancer Treatments Unveiled at ASCO Conference in Chicago
The American Society of Clinical Oncology (ASCO) annual meeting in Chicago showcased significant advancements in cancer treatment. Key highlights included a new drug, GRWD5769, which helps expose cancer cells to the immune system, and a daily pill, daraxonrasib, that doubles survival time for pancreatic cancer patients. The conference also discussed a genomic test that could allow some breast cancer patients to skip chemotherapy. These developments represent promising steps forward in cancer treatment, offering new hope for patients with previously limited options.